Business
Pfizer’s COVID vaccine success is worth an extra $14 billion to the US pharma giant – ABC News
The success of Pfizer’s mRNA-based COVID vaccine looks set to secure the company a multi-billion-dollar windfall for many years as countries already start booking…
The success of its COVID vaccine, and the challenges faced by some of its rivals, look set to earn US pharmaceutical giant Pfizer at least an extra $US11 billion ($14.2 billion) in revenue this year.
Key points:
- Pfizer has raised its 2021 revenue forecasts for COVID vaccine sales by 73 per cent
- The company is hoping to ramp up production to 2.5 billion doses this year and three billion in 2022
- Pfizer is evaluating a prototype to include the South African variant and expects annual flu-style vaccinations…
Continue Reading
-
General21 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News21 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General23 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News23 hours agoUpdate: Attempted murder charges, Maroochydore